ARANESP 500 mcg a système protection ser pré
7680557250733
CH-55725
B03XA02
06.07.3.
Reimbursement limitations:
ARANESP4
Anémie rénale lors d'une insuffisance rénale: 17807.1
Le code d’indication suivant doit être transmis: 17807.1
…
1 / 3
google
Details
- Product number
- 5572512
- CPT
- -
- Packaging group
- 1
- Unit
- Spritze(n)
- Composition
- darbepoetinum alfa 500 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml, natrium 3.79 mg.
Articles (1)
Aranesp 500 Mikrogramm, Injektionslösung in Fertigspritze
Injektionslösung in Fertigspritze
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.79 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1147.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2004
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 55725
- Drug name
- Aranesp, Injektionslösung in Fertigspritze
- Galenic form
- INLFS
- ATC Code
- B03XA02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/09/2002
- Authorization expiration date
- 31/12/9999
- IT number
- 06.07.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ARANESP 500 mcg a système protection ser pré
- Description (DE)
- ARANESP 500 mcg m Nadelschutz Fertspr
- Market launch
- 17/04/2003
- Narcotic (BTM)
- No